GEODE CAPITAL MANAGEMENT, LLC
Position in AQST — Aquestive Therapeutics, Inc.
CIK 1214717
BOSTON, MA
Position in AQST
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$10,911,213
+$917,222 QoQ
Shares Held
2,622,888
+8.9% QoQ
Ownership
2.09%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#7
of 185 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AQST Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026GEODE CAPITAL MANAGEMENT, LLC holds $4,788,152,578 across 66 Drug Manufacturers - Specialty & Generic names. AQST ranks #32 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
13,289,622 | $954,992,236 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
996,598 | $539,986,694 | |
| 3 | VTRS |
Viatris Inc
|
32,807,906 | $520,989,547 | |
| 4 | TEVA |
Teva Pharmaceutical Industries Ltd
|
11,607,196 | $393,251,799 | |
| 5 | NBIX |
Neurocrine Biosciences Inc
|
2,138,777 | $360,469,474 | |
| 6 | ELAN |
Elanco Animal Health Inc
|
11,302,057 | $278,143,622 | |
| 7 | ALKS |
Alkermes plc.
|
4,477,876 | $234,640,702 | |
| 8 | LNTH |
Lantheus Holdings, Inc.
|
1,841,367 | $204,281,254 |
All Filings in AQST
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $10,911,213 | 2,622,888 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $9,993,991 | 2,408,191 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $15,297,873 | 2,368,092 | Shares | Defined | 2026-02-09 | |
| 2025-09-30 | $11,671,628 | 2,087,948 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $6,543,872 | 1,977,001 | Shares | Defined | 2025-08-08 | |
| 2025-03-31 | $4,932,047 | 1,700,706 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $5,890,361 | 1,654,596 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $8,304,224 | 1,667,515 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $4,100,127 | 1,576,972 | Shares | Defined | 2024-08-09 | |
| 2024-03-31 | $2,293,822 | 538,456 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $999,702 | 494,902 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $698,544 | 456,565 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $678,112 | 410,977 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $441,835 | 387,575 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $349,592 | 387,575 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $428,101 | 365,899 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $156,391 | 244,362 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $664,237 | 254,497 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $989,211 | 254,296 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $957,630 | 219,640 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $871,978 | 219,642 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $1,845,251 | 354,856 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $1,676,283 | 313,324 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $1,337,154 | 275,418 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $1,314,367 | 270,446 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $326,504 | 149,089 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||